UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the six months ended June 30, 2025
Commission
File No. 001-41010
MAINZ
BIOMED N.V.
(Translation
of registrant’s name into English)
Robert
Koch Strasse 50
55129 Mainz
Germany
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Other
Events
On
September 26, 2025, Mainz Biomed N.V. made available its Management’s Discussion
and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025. A copy of the report is attached
hereto as Exhibit 99.1.
On
September 26, 2025, Mainz Biomed N.V. made available its unaudited Financial Statements
for the six months ended June 30, 2025. A copy of the report is attached hereto as Exhibit 99.2.
This
current report on Form 6-K and exhibits 99.1 and 99.2 hereto are hereby incorporated by reference into the Company’s Registration
Statement on Form F-3 (File No. 333-269091) and its registration statement on Form S-8 (File No. 333-273203).
| Exhibit
No. |
|
Exhibit |
| 99.1 |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations of Mainz Biomed N.V. for the six months ended June 30, 2025 |
| 99.2 |
|
Unaudited Financial Statements of Mainz Biomed N.V. as of, and for the six months ended, June 30, 2025 |
| 101.INS |
|
Inline XBRL Instance Document. |
| 101.SCH |
|
Inline XBRL Taxonomy Extension
Schema Document. |
| 101.CAL |
|
Inline XBRL Taxonomy Extension
Calculation Linkbase Document. |
| 101.DEF |
|
Inline XBRL Taxonomy Extension
Definition Linkbase Document. |
| 101.LAB |
|
Inline XBRL Taxonomy Extension
Label Linkbase Document. |
| 101.PRE |
|
Inline XBRL Taxonomy Extension
Presentation Linkbase Document. |
| 104 |
|
Cover Page Interactive
Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Date: September
26, 2025 |
By: |
/s/
William J. Caragol |
| |
Name: |
William J. Caragol |
| |
Title |
Chief Financial Officer |
2
